These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 16415916)

  • 1. Pharmacovigilance in a genomic era.
    Farahani P; Levine M
    Pharmacogenomics J; 2006; 6(3):158-61. PubMed ID: 16415916
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacogenetics and pharmacovigilance.
    Howland RH
    Drug Saf; 2009; 32(3):265-70. PubMed ID: 19338384
    [No Abstract]   [Full Text] [Related]  

  • 3. Spontaneous reports and pharmacogenetics: the role of the pharmacovigilance centre.
    van Puijenbroek E; Conemans J; van Grootheest K
    Drug Saf; 2009; 32(4):357-8. PubMed ID: 19388726
    [No Abstract]   [Full Text] [Related]  

  • 4. Applying quantitative methods for detecting new drug safety signals in pharmacovigilance national database.
    Shalviri G; Mohammad K; Majdzadeh R; Gholami K
    Pharmacoepidemiol Drug Saf; 2007 Oct; 16(10):1136-40. PubMed ID: 17705214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacovigilance in New Zealand: the role of the New Zealand Pharmacovigilance Centre in facilitating safer medicines use.
    Kunac DL; Harrison-Woolrych M; Tatley MV
    N Z Med J; 2008 Oct; 121(1283):76-89. PubMed ID: 18841188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacovigilance of antimalarial treatment in Uganda: community perceptions and suggestions for reporting adverse events.
    Bukirwa H; Nayiga S; Lubanga R; Mwebaza N; Chandler C; Hopkins H; Talisuna AO; Staedke SG
    Trop Med Int Health; 2008 Sep; 13(9):1143-52. PubMed ID: 18631312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence in pharmacovigilance: extracting adverse drug reactions articles from MEDLINE to link them to case databases.
    Garcelon N; Mougin F; Bousquet C; Burgun A
    Stud Health Technol Inform; 2006; 124():528-33. PubMed ID: 17108572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of hospital and community pharmacists in pharmacovigilance.
    van Grootheest AC; de Jong-van den Berg LT
    Res Social Adm Pharm; 2005 Mar; 1(1):126-33. PubMed ID: 17138470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse drug reactions in patients older than 70 years during the heat wave occurred in France in summer 2003: A study from the French PharmacoVigilance Database.
    Michenot F; Sommet A; Bagheri H; Lapeyre-Mestre M; Montastruc JL;
    Pharmacoepidemiol Drug Saf; 2006 Oct; 15(10):735-40. PubMed ID: 16924603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Objective registration and interpretation of adverse events caused by vaccines: an essential element of vaccination].
    Boot HJ
    Ned Tijdschr Geneeskd; 2007 Dec; 151(49):2707-8. PubMed ID: 18225788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National pharmacovigilance program.
    Srivastava RN
    Indian Pediatr; 2006 May; 43(5):458; author reply 458-9. PubMed ID: 16735778
    [No Abstract]   [Full Text] [Related]  

  • 12. APVMA veterinary pharmacovigilance program: suspected adverse experience reports for 2005.
    Linnett PJ
    Aust Vet J; 2006 Dec; 84(12):418-20. PubMed ID: 17156321
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacovigilance as new direction of research].
    Gaszner G; Makkos Z; Gaszner P
    Neuropsychopharmacol Hung; 2005 Dec; 7(4):194-8. PubMed ID: 16496484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-induced psoriasis: results from pharmacovigilance tools under investigation.
    Hauben M; Reich L; Magliano S; Song A
    Cutan Ocul Toxicol; 2008; 27(1):55-9. PubMed ID: 18330834
    [No Abstract]   [Full Text] [Related]  

  • 15. Adverse drug reaction active surveillance: developing a national network in Canada's children's hospitals.
    Carleton B; Poole R; Smith M; Leeder J; Ghannadan R; Ross C; Phillips M; Hayden M
    Pharmacoepidemiol Drug Saf; 2009 Aug; 18(8):713-21. PubMed ID: 19507171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacovigilance--a commitment of medical professional.
    Daga S
    J Indian Med Assoc; 2008 Dec; 106(12):775. PubMed ID: 19370945
    [No Abstract]   [Full Text] [Related]  

  • 17. European commission consultation on pharmacovigilance.
    Waller P; Beard K; Egberts T; Evans S; Hallas J; Hasford J; Laporte JR; Moore N; Shakir S; Sturkenboom M
    Pharmacoepidemiol Drug Saf; 2008 Feb; 17(2):108-9. PubMed ID: 18058839
    [No Abstract]   [Full Text] [Related]  

  • 18. Assessment of utilization and pharmacovigilance based on spontaneous adverse event reporting of gadopentetate dimeglumine as a magnetic resonance contrast agent after 45 million administrations and 15 years of clinical use.
    Knopp MV; Balzer T; Esser M; Kashanian FK; Paul P; Niendorf HP
    Invest Radiol; 2006 Jun; 41(6):491-9. PubMed ID: 16763467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacovigilance studies in haemophilia.
    Ingerslev J
    Haemophilia; 2007 Mar; 13(2):121-3. PubMed ID: 17286763
    [No Abstract]   [Full Text] [Related]  

  • 20. New guideline for tramadol usage following adverse drug reactions reported to the Iranian Pharmacovigilance Center.
    Gholami K; Shalviri G; Zarbakhsh A; Daryabari N; Yousefian S
    Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):229-37. PubMed ID: 17063533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.